SANARA MEDTECH INC. - COMMON STOCK

Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd

21 يناير 2025 15:10:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments

21 يناير 2025 15:08:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024

21 يناير 2025 15:05:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th

25 نوفمبر 2024 15:05:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Reports Third Quarter 2024 Results

12 نوفمبر 2024 15:15:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates

31 أكتوبر 2024 08:15:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Changes to Its Board of Directors

07 أكتوبر 2024 08:15:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Second Quarter 2024 Results

12 أغسطس 2024 15:15:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates

30 يوليو 2024 08:15:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces First Quarter 2024 Results

13 مايو 2024 08:15:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates

29 أبريل 2024 08:15:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces $55 Million Debt Facility

18 أبريل 2024 08:15:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer

05 أبريل 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results

25 مارس 2024 15:05:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates

13 مارس 2024 08:15:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023

22 فبراير 2024 08:15:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides

03 يناير 2024 08:15:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing

30 نوفمبر 2023 08:15:00 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Third Quarter 2023 Results

13 نوفمبر 2023 15:05:01 بحسب Nasdaq GlobeNewswire

Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates

30 أكتوبر 2023 08:15:00 بحسب Nasdaq GlobeNewswire